Cargando…
Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCC
SIMPLE SUMMARY: Tumors use immunosuppressive signals to evade detection by the immune system. While recurrent and metastatic head and neck squamous cell carcinoma has historically carried a poor prognosis, therapies targeting the immunosuppressive PD1:PDL1 axis have improved survival in certain pati...
Autores principales: | Mann, Jacqueline E, Ludwig, Megan L, Kulkarni, Aditi, Scheftz, Erin B, Murray, Isabel R, Zhai, Jingyi, Gensterblum-Miller, Elizabeth, Jiang, Hui, Brenner, J Chad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508280/ https://www.ncbi.nlm.nih.gov/pubmed/34638266 http://dx.doi.org/10.3390/cancers13194782 |
Ejemplares similares
-
Protecting Tumors by Preventing Human Papilloma Virus Antigen Presentation: Insights from Emerging Bioinformatics Algorithms
por: Gensterblum-Miller, Elizabeth, et al.
Publicado: (2019) -
Synthesis of Novel Peptide Dendrimers PDL-GB2 and PDL-G2
por: Yunzhu, Lin, et al.
Publicado: (2015) -
Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC
por: Mann, JE, et al.
Publicado: (2017) -
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects
por: Bai, Haiyan, et al.
Publicado: (2023) -
Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis
por: Fan, Yujing, et al.
Publicado: (2021)